Public signalCompany raiseAuto-indexed · Unverified

Clover Biopharmaceuticals, Ltd. raised $905K

Clover Biopharmaceuticals, Ltd.· CHENGDU, CHINA· Biotechnology· Filed Apr 28, 2025

Clover Biopharmaceuticals, Ltd. reported raising capital. Based in CHENGDU, CHINA. First sale reported 2024-04-02. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$904,859
Confidence90%
Raised
$904,859
Investors
13
Jurisdiction
CAYMAN ISLANDS

On the record

Location
CHENGDU, CHINA
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$904,859
Target amount
$904,859
Filing date
Apr 28, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
CAYMAN ISLANDS
Industry group
Biotechnology
Number of investors
13
Includes non-accredited investors
Yes
Revenue range
Decline to Disclose
Total offering amount
$904,859
Amendment
Yes

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 904,859 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Apr 28, 2025. Details beyond the filing have not been verified.

Tags

AmendmentCHINACompanyBiotechnology$100K – $1MCompany Raise

Are you associated with Clover Biopharmaceuticals, Ltd.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record